Reply: The expanding neurological phenotype of DNM1L-related disorders.
暂无分享，去创建一个
N. Boddaert | D. Bonneau | P. Amati‐Bonneau | G. Lenaers | P. Reynier | V. Procaccio | S. Leruez | D. Bouccara | B. Funalot | C. Hamel | A. Chevrollier | Jennifer Alban | C. Delettre | M. Rio | I. Meunier | S. Gerber | J. Kaplan | J. Rozet | R. Calmon | H. Sesaki | Selma Kane | A. Paris | Mélanie Quilès | M. Charif | Tanguy Chaumette | Claire Angebault
[1] Michael F. Wangler,et al. The expanding neurological phenotype of DNM1L-related disorders. , 2018, Brain : a journal of neurology.
[2] N. Boddaert,et al. Mutations in DNM1L, as in OPA1, result indominant optic atrophy despite opposite effectson mitochondrial fusion and fission , 2017, Brain : a journal of neurology.
[3] H. Bellen,et al. Missense variants in the middle domain of DNM1L in cases of infantile encephalopathy alter peroxisomes and mitochondria when assayed in Drosophila. , 2016, Human molecular genetics.
[4] N. Boddaert,et al. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. , 2012, Brain : a journal of neurology.
[5] M. Mańczak,et al. Dynamin-related protein 1 heterozygote knockout mice do not have synaptic and mitochondrial deficiencies. , 2012, Biochimica et biophysica acta.
[6] V. Mils,et al. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: Relevance to ADOA pathogenesis , 2007, Journal of cellular physiology.